e-learning
resources
Vienna 2003
Monday 29.09.2003
Immunology of interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting
Y. Lebedin, M. Zhdanovich, K. Dulin, S. Avdeev (Moscow, Russia)
Source:
Annual Congress 2003 - Immunology of interstitial lung diseases
Session:
Immunology of interstitial lung diseases
Session type:
Poster Discussion
Number:
1522
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Lebedin, M. Zhdanovich, K. Dulin, S. Avdeev (Moscow, Russia). High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting. Eur Respir J 2003; 22: Suppl. 45, 1522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD)
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Serum IgG and IgA antibodies to chramydia pneumoniae and severity of emphysema
Source: Eur Respir J 2004; 24: Suppl. 48, 44s
Year: 2004
Altered IgG but normal IgA responses to pneumococcal proteins in lung fluid and serum in HIV infected adults
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
Detection of serum anti-endothelial cell antibodies (AECA) in COPD rats
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012
Altered Fc galactosylation in IgG
4
is a potential serum marker for chronic lung disease
Source: ERJ Open Res, 4 (3) 00033-2018; 10.1183/23120541.00033-2018
Year: 2018
The association of serum IgG antibody with symptoms of hypersensitivity pneumonitis
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006
Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
MEMP1972A, an anti-M1 prime monoclonal antibody, reduces serum IgE in healthy and allergic rhinitis subjects
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012
Relationship of serum immunoglobulines and IgG subclasses in previously healthy adult patients with community acquired pneumonia
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Late Breaking Abstract - The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021
Detection of antibodies against recoverin in the serum of patients with small cell lung cancer in the absence of cancer-associated retinopathy
Source: Eur Respir J 2001; 18: Suppl. 33, 395s
Year: 2001
IgG4 disease and the lung
Source: International Congress 2016 – Lung involvement in systemic disorders
Year: 2016
Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
The importance of quantifying serum antibody associated with allergic alveolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 355s
Year: 2004
Sputum autoantibodies are more relevant in autoimmune responses in asthma than are serum autoantibodies
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF)
Source: Eur Respir J 2007; 30: Suppl. 51, 648s
Year: 2007
An association between sarcoidosis and serum immunoglobulin levels
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept